Login to Your Account

Actelion, Roche Sign $630M Autoimmunity Product Deal

By Cormac Sheridan

Wednesday, July 19, 2006
Shrugging off recent disappointments in the clinic, Actelion AG signed what is likely to be one of the landmark licensing deals in European biotechnology in 2006. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription